Spectaire Unveils AireCore 2.0: Opening New Revenue Opportunities in Pharmaceuticals, Environmental Analysis, and Advanced Materials Research
2024年7月10日 - 9:00PM
Spectaire Holdings Inc. (NASDAQ: SPEC) (“Spectaire” or the
“Company”), a pioneer in environmental measurement technology,
today announced the upcoming release of AireCore 2.0, the next
generation in micro mass spectrometry. Scheduled for shipment in Q1
2025, AireCore 2.0 will feature Double Focusing Mass Spectrometry
(DFMS), a significant advancement over the previous Single Focusing
Mass Spectrometry (SFMS) technology, positioning the Company for
new revenue streams and substantial market opportunities.
Key Enhancements with DFMS:
- Enhanced
Resolution and Accuracy: DFMS technology allows for
greater separation of ions with similar mass-to-charge ratios,
providing higher resolution and more accurate mass
determinations.
- Broader
Analytical Range: DFMS expands the range of detectable
molecules, including those with higher masses and more complex
structures.
These advancements will enable the identification of a wider
array of substances, including complex organic and biological
molecules. As a result, AireCore 2.0 will open new markets for
Spectaire, including pharmaceuticals, environmental analysis,
agricultural monitoring, and advanced materials research, while
continuing to enhance capabilities in the Company’s core industries
such as logistics and energy.
The global mass spectrometry market is expected to reach $15.6
billion by 2033, growing at a CAGR of 8.9%, according to Precedence
Research. The enhanced capabilities of AireCore 2.0 significantly
strengthen Spectaire’s ability to capitalize on this growth. The
increased resolution and sensitivity will attract more customers
seeking precise, reliable, and cost-effective solutions, ultimately
driving significant revenue growth for Spectaire.
Dr. Brian Hemond, Chief Technology Officer of Spectaire,
commented on this development: “AireCore 2.0 is the natural
evolution of the AireCore platform. By incorporating a double
focusing mass analyzer, we significantly expand our intellectual
property differentiation. This new system maintains our primary
vision of providing price-accessible, easy-to-use, in-situ,
real-time spectral analysis, while delivering enhanced resolution
essential for applications such as identifying heavier fuel
hydrocarbons in process controls and analyzing biologically
important compounds like pharmaceuticals and respiratory
products.”
Brian Semkiw, CEO of Spectaire, also highlighted the strategic
impact of AireCore 2.0: “The introduction of AireCore 2.0 not only
strengthens our position in existing markets such as logistics and
energy but also allows us to broaden our installations at current
clients while becoming a new platform solution for other industries
like pharmaceuticals and environmental analysis. AireCore
revolutionized environmental measurement by bringing mass
spectrometers out of the labs and into the field, and with AireCore
2.0, we are excited to broaden the industries we serve. This
technological leap underscores our commitment to driving innovation
and expanding our market reach with cutting-edge technology.”
Spectaire is poised to revolutionize the field of micro mass
spectrometry with AireCore 2.0, setting a new standard for accuracy
and accessibility.
For more information about AireCore 2.0 and its upcoming
release, please visit https://www.spectaire.com.
About Spectaire Holdings Inc.
Spectaire Holdings Inc. (NASDAQ: SPEC) is a pioneering company
in the field of environmental measurement technology, dedicated to
developing innovative solutions that provide accurate, accessible,
and efficient analytical capabilities across various industries.
Our mission is to enhance scientific and industrial processes
through advanced spectral analysis technologies.
For additional information,
contact:IR@spectaire.com
Dave GentryRedChip Companies,
Inc.1-800-733-24471-407-491-4498SPEC@redchip.com
Forward-Looking Statements: This release contains certain
forward-looking statements within the meaning of the federal
securities laws. These forward-looking statements generally are
identified by the words “believe,” “project,” “expect,”
“anticipate,” “estimate,” “intend,” “strategy,” “future,”
“opportunity,” “plan,” “may,” “should,” “would,” “will continue,”
“will likely result” and similar expressions. The forward-looking
statements are based on the current expectations of the management
of Spectaire and are inherently subject to uncertainties and
changes in circumstances and their potential effects and speak only
as of the date of such statement. There can be no assurance that
future developments will be those that have been anticipated.
Forward-looking statements reflect material expectations and
assumptions, including, without limitation, expectations, and
assumptions. Such expectations and assumptions are inherently
subject to uncertainties and contingencies regarding future events
and, as such, are subject to change. Forward-looking statements
involve a number of risks, uncertainties, or other factors that may
cause actual results or performance to be materially different from
those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to,
those discussed and identified in public filings made by Spectaire
with the U.S. Securities and Exchange Commission (the “SEC”) and
the following: Spectaire’s ability to operate as a going concern;
Spectaire’s requirement of significant additional capital;
Spectaire’s limited operating history; Spectaire’s history of
losses; Spectaire’s ability to attract qualified management;
Spectaire’s ability to adapt to rapid and significant technological
change and respond to introductions of new products in order to
remain competitive; the loss of, or nonperformance by, one or more
significant customers; disruptions of Spectaire’s manufacturing
operation; changes in governmental regulations reducing demand for
Spectaire’s products or increasing Spectaire’s expenses; the
effects of global health crises on Spectaire’s business plans,
financial condition and liquidity; changes or disruptions in the
securities markets; legislative, political or economic
developments; Spectaire’s failure to obtain any necessary permits
or comply with laws and regulations and other regulatory
requirements; accidents, equipment breakdowns, labor disputes or
other unanticipated difficulties or interruptions; potential cost
overruns or unanticipated expenses in development programs;
potential legal proceedings; and Spectaire’s failure to obtain or
maintain insurance covering all of Spectaire’s operations. Should
one or more of these risks or uncertainties materialize or should
any of the assumptions made by the management of Spectaire prove
incorrect, actual results may vary in material respects from those
projected in these forward-looking statements. All subsequent
written and oral forward-looking statements concerning matters
addressed herein and attributable to Spectaire or any person acting
on its behalf are expressly qualified in their entirety by the
cautionary statements contained or referred to herein. Except to
the extent required by applicable law or regulation, Spectaire
undertakes no obligation to update these forward-looking statements
to reflect events or circumstances after the date hereof to reflect
the occurrence of unanticipated events.
No Offer: This communication is for informational purposes only
and shall neither constitute an offer to sell nor the solicitation
of an offer to buy any securities, nor shall there be any sale of
securities in any jurisdiction in which the offer, solicitation, or
sale would be unlawful prior to the registration or qualification
under the securities laws of any such jurisdictions. No offering of
securities shall be made except by means of a prospectus meeting
the requirements of Section 10 of the Securities Act or an
exemption therefrom.
Spectaire (NASDAQ:SPEC)
過去 株価チャート
から 9 2024 まで 10 2024
Spectaire (NASDAQ:SPEC)
過去 株価チャート
から 10 2023 まで 10 2024